Squamous cell carcinoma of skin: A brief review

Clinica Terapeutica

Volumn 164, Issue 2, 2013, Pages 143-147

  Rahimi, Siavash ^a  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

Cancer; Review; SCC; Skin

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P53;

ACANTHOLYSIS; ADENOSQUAMOUS CARCINOMA; CHROMOSOME ABERRATION; GENE MUTATION; HISTOLOGY; HUMAN; KERATINOCYTE; MOLECULAR BIOLOGY; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SKIN CARCINOMA; SPINDLE CELL CARCINOMA; SUN EXPOSURE; TUMOR GROWTH; VERRUCOUS CARCINOMA; WILD TYPE;

CARCINOMA, SQUAMOUS CELL; GENES, P53; HUMANS; SKIN NEOPLASMS;

EID: 84876717502     PISSN: 00099074     EISSN: 19726007     Source Type: Journal    
DOI: 10.7417/CT.2013.1534     Document Type: Review

References (69)

1. British Association of Dermatologists. Guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. British J Dermatol 2002; 146:18-25
2. Jerant AF, Johnson JT, Sheridan CD, et al. Early detection and treatment of skin cancer. Am Fam Physician 2000; 15; 62(2):357-68, 375-6, 381-2
3. Foo CC, Lee JS, Guilanno V, et al. Squamous cell carcinoma and Bowen's disease of the skin in Singapore. Ann Acad Med Singapore 2007; 36(3):189-93
4. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344:975-83
5. Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000; 42(Suppl):S11-7
6. Massari LP, Kastelan M, Gruber F. Epidermal malignant tumors: pathogenesis, influence of UV light and apoptosis. Coll Antropol 2007; 31 (Suppl)1:83-5
7. Johnson WC, Helwig EB. Adenoid squamous cell carcinoma (adenoacanthoma). A clinicopathologic study of 155 patients. Cancer 1966; 19:1639-50
8. Nappi O, Pettinato G, Wick MR. Adenoid (acantholytic) squamous cell carcinoma of the skin. J Cutan Pathol 1989; 16:114-21
9. Petter G, Haustein UF. Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg 2000; 26:521-30
10. Wooldridge WE, Frerichs JB. Multiple adenoid squamous cell carcinoma. Arch Dermatol 1971; 104:202-6
11. Banerjee SS, Eyden BP, Wells S, et al. Pseudoangiosarcomatous carcinoma: aclinicopathological study of seven cases. Histopathol 1992; 21:13-23
12. Nagore E, Sanchez-Motilla JM, Perez-Valles A, et al. Ovascular squamous cell carcinoma of the skin. Clin Exp Dermatol 2000; 25:206-8
13. Nappi O, Wick MR, Pettinato G, et al.ovascular adenoid squamous cell carcinoma of the skin. A neoplasm that may be mistaken for angiosarcoma. Am J Surg Pathol 1992; 16: 429-38
14. Rowe DE, Carroll RJ, Day CLJr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992; 26:976-90
15. Ikegawa S, Saida T, Takizawa Y, et al. Vimentn-positive squamous cell carcinoma arising in a burn scar. A highly malignant neoplasm composed of acantholytic round keratinocytes. Arch Dermatol 1989; 125:1672-16
16. Child FJ, Russell-Jones R, Woolford AJ, et al. Ansence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma. Br J Dermatol 2001; 44:735-44
17. Iyer PV, Leong AS. Poorly differentiated squamous cell carcinomas of the skin can express vimentin. J Cutan Pathol 1992; 19:34-9
18. Burkhardt A. Verrucous carcinoma and carcinoma cuniculatum forms of squamous cell carcinoma? Hautarzt 1986; 37: 373-83
19. Freedberg IM, Eisen AZ, Wolff K, et al. Fitzpatrick's Dermatology in General Medicine 1999; 5th ed. McGraw-Hill: New York
20. Schwartz RA. Verrucous carcinoma of the skin and mucosa. J Am Acad Dermatol 1995; 32:1-21
21. Young RH, Srigley RJ, Amin MB, et al. Atlas of Tumor Pathology. Tumors of the Prostate Gland, Seminal Vesicles, Male Urethra, and Penis 2000; AFIP: Washington, DC
22. Pindborg JJ, Reichart PA, Smith CJ, et al.logical Typing of Cancer and Precancer of the Oral Mucosa, 2nd ed. 1997; Springer: Berlin Heidelberg New York
23. Kato N, Onozuka T, Yasukawa K, et al. Penile hybrid verrucous-squamous carcinoma associated with a superficial inguinal lymph node metastasis. Am J Dermatopathol 2000; 22:339-43
24. Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann NY Acad Sci 2000; 910:127-37
25. Giglia-Mari G, Sarasin A. TP53 mutations in human skin cancers. Hum Mut 2003; 21:217-28
26. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88:323-31
27. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005; 24:2899-908
28. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ 2003; 10:431-42
29. Ziegler A, Jonason A, Simon J, et al. Tumor suppressor gene mutations and photocarcinogenesis. Photochem Photobiol 1996; 69:432-5
30. Jiang W, Ananthaswamy HN, Muller HK, et al. p53 protects against skin cancer induction by UV B radiation. Oncogene 1999; 18:4247-53
31. Sarasin A, Giglia-Mari G. p53 gene mutations in human skin cancers; Exp Dermatol 2002; 11:44-7
32. Nataraj AJ, Trent JC II, Ananthaswamy HN. p53 mutations and photocarcinogenesis. Photochem Photobiol 1995; 62: 218-30
33. Gusterson BA, Anbazhagan R, Warren W, et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 1991; 6:1785-9
34. McGregor JM, Yu CC-W, Dublin EA, et al. Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer. Br J Dermatol 1992; 127:463-9
35. Sim CS, Slater S, McKee PH. Mutant p53 expression in solar keratosis: an immunohistochemical study. J Cutan Pathol 1992; 19:302-8
36. Taguchi M, Watanabe S, Sato Y, et al. Immunohistochemical examination of tumorsuppressor gene p53 and pyrimidine dimer in solar keratosis. J Cancer Res Clin Oncol 1993; 119: 260-2
37. Oram Y, Orengo I, Baer SC, et al. p53 protein expression in squamous cell carcinoma from sun-exposed and nonsunexposed sites. J Am Acad Dermatol 1994; 3:417-22
38. Onodera H, Nakamura S, Sugai T. Cell proliferation and p53 protein expression in cutaneous epithelial neoplasms. Am J Dermatopathol 1996; 18:588-8
39. Shimuzu T, Murakami T, Oga A, et al. Prognostic significance of expression of p53 protein and Ki-67 antigen in well-differentiated squamous cell carcinoma of the skin. J Dermatol 1999; 26:837-40
40. Shimuzu T, Oga A, Murakami T, et al. Overexpression of p53 protein associated with proliferative activity and histological degree of malignancy in solar keratosis. Dermatol 1999; 199:113-8
41. Auepemkiate S, Boonyaphiphat P, Sriplung H. p53 expression in cutaneous squamous cell carcinoma. J Med Assoc Thai 2000; 83:543-8
42. O'Connor DP, Kay EW, Leader M, et al. Altered p53 expression in benign and malignant skin lesions from renal transplant recipients and immunocompetent patients with skin cancer: correlation with human papillomavirus? Diagn Mod Pathol 2001; 10:190-9
43. Verdolini R, Amerio P, Goteri G, et al. Cutaneous carcinoma and preinvasive neoplastic lesions. Role of MMP-2 and MMP-9 metalloproteinases in neoplastic invasion and their relationship with proliferative activity and p53 expression. J Cutan Pathol 2001; 28:120-6
44. Kawakami T, Soma Y, Mizoguchi M, et al. Analysis of p53, p21 (Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease. Dermatol 2001; 202:9-15
45. Blokx WA, de Jong EM, de Wilde PC, et al. p16 and p53 expression in (pre.malignant epidermal tumors of renal transplant recipients and immunocompetent individuals. Mod Pathol 2003; 16:869-78
46. Hussein MR, Al-Badaiwy ZH, Guirguis MN. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions. J Cutan Pathol 2004; 31:643-51
47. Batinac T, Zamolo G, Jonjic N, et al. p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases. Tumori 2004; 90:120-7
48. Park HR, Min SK, Cho HD, et al. Expression profiles of p63, p53, surviving and hTERT in skin tumors. J Cutan Pathol 2004; 31:544-9
49. Carpenter PM, Linder KG, McLaren CE, et al. Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skin. Cancer Epidemiol Biomarkers Prev 2004; 13:1996-2002
50. Jonason AS, Kunala S, Price GJ, et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci U S A 1996; 93:14025-9
51. Liang SB, Ohtsuki R, Furihata M, et al. Sun exposure and aging-dependent p53 protein accumulation results in growth advantage for tumour cells in carcinogenesis of nonmelanocytic skin cancer. Virchows Arch 1999; 434:193-9
52. Urano Y, Asano T, Yoshimoto K, et al. Frequent p53 accumulation in the chronically sunexposed epidermis and clonal expansion of p53 mutant cells in the epidermis adjacent to basal cell carcinoma. J Invest Dermatol 1995; 104:928-32
53. Ren ZP, Ponten F, Nister M, et al. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis. Int J Cancer 1996; 69:174-9
54. Grossman D, Leffell DJ. The molecular basis of nonmelanoma skin cancer: new understanding. Arch Dermatol 1997; 133:1263-70
55. Ziegler A, Jonason AS, Leffell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372:773-6
56. Leffell DJ. The scientific basis of skin cancer. J Am Acad Dermatol 2000; 42:18-22
57. Jonason AS, Kunala S, Price GJ, et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci U S A 1996; 93:14025-9
58. Barzilai A, Lyakhovitsky A, Trau H, et al. Expression of p53 in the evolution of squamous cell carcinoma: Correlation with the histology of the lesion. J Am Acad Dermatol 2007; 57: 669-76
59. Ackerman AB, Mones JM. Solar (actinic. keratosis is squamous cell carcinoma. Br J Dermatol 2006; 155:9-22
60. Coulter LK, Wolber R, Tron VA. Site-specific comparison of p53 immunostaining in squamous cell carcinomas. Hum Pathol 1995; 26:531-3
61. Oppel T, Korting HC. Actinic keratosis: the key event in the evolution from photoaged skin to squamous cell carcinoma. Skin Pharmacol Physiol 2004; 17:67-76
62. Agar NS, Halliday GM, Barnetson RS, et al. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc Natl Acad Sci USA 2004; 101:4954-9
63. Ponten F, Lundeberg J. Principles of tumor biology and pathogenesis of BCCs and SCCs. In: Bolognia JL, Jorizzo JL. J Am Acad Dermatol. Vol. 57, N 4 Barzilai et al 675 Rapini RP, editors. Dermatology. St Louis: Mosby 2003; 1674-5
64. Bataille V. Genetics of familial and sporadic melanoma. Clin Exp Dermatol 2000; 25:464-70
65. Soufir N, Moles JP, Vilmer C, et al. p16 UV mutations in human skin epithelial tumors. Oncogene 1999; 18:5477-81
66. Brown VL, Harwood CA, Crook T, et al. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. J Invest Dermatol 2004; 122:1284-92
67. Saridaki Z, Liloglou T, Zaridopoulos A, et al. Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin. Br J Dermatol 2003; 148:638-48
68. Liggett WH Jr, Sidransky D. Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 1998; 16:1197- 206
69. Pacifico A, Goldberg LH, Peris K, et al. Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers. Br J Dermatol 2008; 158:291-7